Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sewall LM"'
Autor:
Hahn WO; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA., Parks KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Shen M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Janes H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Ballweber-Fleming L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Woodward Davis AS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Duplessis C; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Tomai M; 3M Healthcare , St. Paul, MD, USA., Dey AK; International AIDS Vaccine Initiative , New York, NY, USA., Sagawa ZK; Access to Advanced Health Institute , Seattle, WA, USA., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Seese A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Kallur Siddaramaiah L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Stamatatos L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Lee WH; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Karlinsey D; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Turner HL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Rubin V; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Furth S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., MacPhee K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Duff M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Keefer MC; Department of Medicine, University of Rochester, Rochester, NY, USA., Edupuganti S; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA., Frank I; School of Medicine, University of Pennsylvania , Philadelphia, PA, USA., Maenza J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA., Baden LR; Brigham and Women's Hospital , Boston, MA, USA., Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Sanders RW; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands., Moore JP; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Tomaras GD; Center for Human Systems Immunology and Departments of Surgery and Integrative Immunobiology, Duke University School of Medicine, Durham, NC, USA., Montefiori DC; Department of Surgery, Duke University, Durham, NC, USA., Rouphael N; Hope Clinic, Emory University , Atlanta, GA, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2024 Oct 07; Vol. 221 (10). Date of Electronic Publication: 2024 Sep 05.
Autor:
Altman PX; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America., Ozorowski G; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Stanfield RL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Haakenson J; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States of America.; Applied Biomedical Science Institute, San Diego, California, United States of America., Appel M; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America., Parren M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Lee WH; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Sang H; Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medical, Kansas State University, Manhattan, Kansas, United States of America., Woehl J; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America., Saye-Francisco K; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Joyce C; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America., Song G; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America., Porter K; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Landais E; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America., Andrabi R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., Wilson IA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, United States of America., Ward AB; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Mwangi W; Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medical, Kansas State University, Manhattan, Kansas, United States of America., Smider VV; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States of America.; Applied Biomedical Science Institute, San Diego, California, United States of America., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America., Sok D; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America.; Global Health Investment Corporation, New York, New York, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2024 Sep 09; Vol. 20 (9), pp. e1012042. Date of Electronic Publication: 2024 Sep 09 (Print Publication: 2024).
Autor:
Nelson AN; Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA., Shen X; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Vekatayogi S; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Zhang S; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA, USA., Ozorowski G; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA, USA., Dennis M; Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA., Sewall LM; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA, USA., Milligan E; Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Davis D; Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Cross KA; Gillings School of Public Health and Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Chen Y; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., van Schooten J; Department of Medical Microbiology, Academic Medical Center, Amsterdam, Netherlands., Eudailey J; Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA., Isaac J; Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA., Memon S; Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA., Weinbaum C; Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA., Gao H; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Stanfield-Oakley S; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Byrd A; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Chutkan S; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Berendam S; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Cronin K; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Yasmeen A; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA., Alam S; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., LaBranche CC; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Rogers K; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Shirreff L; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Cupo A; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA., Derking R; Department of Medical Microbiology, Academic Medical Center, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands., Villinger F; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Klasse PJ; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA., Ferrari G; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Williams WB; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Hudgens MG; Gillings School of Public Health and Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Ward AB; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA, USA., Montefiori DC; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Van Rompay KKA; California National Primate Research Center, University of California, Davis, CA, USA., Wiehe K; Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Moore JP; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA., Sanders RW; Department of Medical Microbiology, Academic Medical Center, Amsterdam, Netherlands.; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands., De Paris K; Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Permar SR; Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA.
Publikováno v:
Science immunology [Sci Immunol] 2024 Aug 30; Vol. 9 (98), pp. eadm7097. Date of Electronic Publication: 2024 Aug 30.
Autor:
Cottrell CA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Pratap PP; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Cirelli KM; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Carnathan DG; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, 30329, USA., Enemuo CA; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, 30329, USA., Antanasijevic A; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Gao H; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, Durham, NC, USA., Allen JD; School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK., Nogal B; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA., Silva M; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Bhiman J; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Pauthner M; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Irvine DJ; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Montefiori D; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center Durham, Durham, NC, USA., Crispin M; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK., Burton DR; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Silvestri G; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, 30329, USA., Crotty S; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.; La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.; Division of Infectious Disease and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, CA, USA., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA. andrew@scripps.edu.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA. andrew@scripps.edu.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2024 Jul 12; Vol. 9 (1), pp. 126. Date of Electronic Publication: 2024 Jul 12.
Autor:
Hahn WO, Parks KR, Shen M, Ozorowski G, Janes H, Ballweber-Fleming L, Woodward Davis AS, Duplessis C, Tomai M, Dey AK, Sagawa ZK, De Rosa SC, Seese A, Siddaramaiah LK, Stamatatos L, Lee WH, Sewall LM, Karlinsey D, Turner HL, Rubin V, Furth S, MacPhee K, Duff M, Corey L, Keefer MC, Edupuganti S, Frank I, Maenza J, Baden LR, Hyrien O, Sanders RW, Moore JP, Ward AB, Tomaras GD, Montefiori DC, Rouphael N, McElrath MJ
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 May 09. Date of Electronic Publication: 2024 May 09.
Autor:
Brown S; Department of Integrative, Structural and Computational Biology, Scripps Research; La Jolla, CA, USA., Antanasijevic A; Global Health Institute, École Polytechnique Fédérale de Lausanne; Lausanne, Switzerland., Sewall LM; Department of Integrative, Structural and Computational Biology, Scripps Research; La Jolla, CA, USA., Garcia DM; Department of Integrative, Structural and Computational Biology, Scripps Research; La Jolla, CA, USA., Brouwer PJM; Department of Integrative, Structural and Computational Biology, Scripps Research; La Jolla, CA, USA., Sanders RW; Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam; Amsterdam, The Netherlands., Ward AB; Department of Integrative, Structural and Computational Biology, Scripps Research; La Jolla, CA, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Mar 17. Date of Electronic Publication: 2024 Mar 17.
Autor:
Nelson AN; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA., Shen X; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Vekatayogi S; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Zhang S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Dennis M; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA., Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Milligan E; Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill; Chapel Hill, NC, USA., Davis D; Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill; Chapel Hill, NC, USA., Cross KA; Gillings School of Public Health and Center for AIDS Research, University of North Carolina at Chapel Hill; Chapel Hill, NC, USA., Chen Y; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., van Schooten J; Department of Medical Microbiology, Academic Medical Center; Amsterdam, Netherlands., Eudailey J; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA., Isaac J; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA., Memon S; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA., Weinbaum C; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA., Stanfield-Oakley S; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Byrd A; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Chutkan S; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Berendam S; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Cronin K; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Yasmeen A; Department of Microbiology and Immunology, Weill Cornell Medicine; New York, NY, USA., Alam SM; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., LaBranche CC; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Rogers K; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Shirreff L; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Cupo A; Department of Microbiology and Immunology, Weill Cornell Medicine; New York, NY, USA., Derking R; Department of Medical Microbiology, Academic Medical Center; Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands., Villinger F; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Klasse PJ; Department of Microbiology and Immunology, Weill Cornell Medicine; New York, NY, USA., Ferrari G; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Williams WB; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Hudgens MG; Gillings School of Public Health and Center for AIDS Research, University of North Carolina at Chapel Hill; Chapel Hill, NC, USA., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Montefiori DC; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Van Rompay KKA; California National Primate Research Center, University of California; Davis, CA, USA., Wiehe K; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA., Moore JP; Department of Microbiology and Immunology, Weill Cornell Medicine; New York, NY, USA., Sanders RW; Department of Medical Microbiology, Academic Medical Center; Amsterdam, Netherlands.; Department of Microbiology and Immunology, Weill Cornell Medicine; New York, NY, USA.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands., De Paris K; Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill; Chapel Hill, NC, USA., Permar SR; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Nov 11. Date of Electronic Publication: 2023 Nov 11.
Autor:
Turner HL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: hannaht@scripps.edu., Jackson AM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Richey ST; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Antanasijevic A; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Hangartner L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: andrew@scripps.edu.
Publikováno v:
STAR protocols [STAR Protoc] 2023 Sep 15; Vol. 4 (3), pp. 102476. Date of Electronic Publication: 2023 Jul 28.
Autor:
Cottrell CA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA., Pratap PP; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA., Cirelli KM; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA., Carnathan DG; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA., Enemuo CA; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA., Antanasijevic A; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA., Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA., Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA., Gao H; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center, Durham, NC, USA., Greene KM; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center, Durham, NC, USA., Allen JD; School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK., Ngo JT; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA., Choe Y; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA., Nogal B; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA., Silva M; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Bhiman J; Centre for HIV and STI, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa., Pauthner M; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA02139, USA., Irvine DJ; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Montefiori D; Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center, Durham, NC, USA., Crispin M; School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK., Burton DR; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA02139, USA., Silvestri G; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA., Crotty S; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Division of Infectious Disease and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California, USA., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Jun 27. Date of Electronic Publication: 2023 Jun 27.
Autor:
Torrents de la Peña A; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., de Paiva Froes Rocha R; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Jackson AM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Pratap PP; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Bangaru S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Cottrell CA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Mohanty S; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA., Shaw AC; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Publikováno v:
Cell reports methods [Cell Rep Methods] 2023 Jun 05; Vol. 3 (6), pp. 100509. Date of Electronic Publication: 2023 Jun 05 (Print Publication: 2023).